论文投稿修回催稿资料下载.pdf
《论文投稿修回催稿资料下载.pdf》由会员分享,可在线阅读,更多相关《论文投稿修回催稿资料下载.pdf(31页珍藏版)》请在冰点文库上搜索。
a:
1:
{i:
0;s:
10646:
"DisclaimerThetemplatesarepreparedbyMedjadenBioscienceLimited(,)asreferences,forourfellowChineseinvestigatorstopublishtheirresearcharticlesinEnglishjournals.Medjadenencouragesauthorstousethetemplatesinacreativewaybecausethesituationofeveryarticleisuniqueandisdifferentfromeachother.Copy/pasteofthistemplatewithoutconsiderationoftheuniquenatureofthearticlemayleadtotherejectionofthearticle.Medjadenisnotresponsible,inanyway,foranynegativedecisionmadebythejournals.生物医学论文投稿、修回、校样及发表相关事宜生物医学论文投稿、修回、校样及发表相关事宜信件模板及实例信件模板及实例美捷登编写2010年10月版权所有,转贴请注明来源DisclaimerThetemplatesarepreparedbyMedjadenBioscienceLimited(,)asreferences,forourfellowChineseinvestigatorstopublishtheirresearcharticlesinEnglishjournals.Medjadenencouragesauthorstousethetemplatesinacreativewaybecausethesituationofeveryarticleisuniqueandisdifferentfromeachother.Copy/pasteofthistemplatewithoutconsiderationoftheuniquenatureofthearticlemayleadtotherejectionofthearticle.Medjadenisnotresponsible,inanyway,foranynegativedecisionmadebythejournals.TableofContents投稿信(Coverletter).3催稿信(Reminderletter).5回复信(Reply/ResponseLetter).6申诉信(Appealletter).12延时修回申请信(Requestforextensionofthedeadline).14作者顺序更改信(AuthorChangeRequestLetter).16费用减免申请信(ConcessionRequestLetter).17撤稿申请信(WithdrawalRequestLetter).19给作者全文索取信(ReprintRequestLettertoAuthor).20作者职责、版权转让及利益冲突声明样本(ExamplesforAuthorsResponsibilityandCopyrightTransfer,DeclarationofConflictofInterest).21例一JournalofClinicalGastroenterology.21例二Cancer.22例三Gastroenterology.25例四AlimentaryPharmacology&@#@Therapeutics.26例五DrugSafety.28校样及单行本订单样本(ExamplesforProofsandReprintOrderForm).31例一AlimentaryPharmacology&@#@Therapeutics.31例二Cancer.31DisclaimerThetemplatesarepreparedbyMedjadenBioscienceLimited(,)asreferences,forourfellowChineseinvestigatorstopublishtheirresearcharticlesinEnglishjournals.Medjadenencouragesauthorstousethetemplatesinacreativewaybecausethesituationofeveryarticleisuniqueandisdifferentfromeachother.Copy/pasteofthistemplatewithoutconsiderationoftheuniquenatureofthearticlemayleadtotherejectionofthearticle.Medjadenisnotresponsible,inanyway,foranynegativedecisionmadebythejournals.投稿信投稿信(Coverletter)(Pleasedeletetheannotationsinitalicintheparentheses.)EditorialOffice,XXXXXXX(AddressoftheEditorialOffice)October21,2010(foranAmericanjournal)21October2010(foraBritishorEuropeanJournal)DearEditor,Wewouldliketosubmitanoriginal(orareview)articleentitled“XXXX(titleofthearticle)forconsiderationforpublicationinXXXX(nameofthejournal).(Youmayuseoneparagraphtosummarizethesignificanceormeritsofthepresentstudyhere.)Thisarticlehasnotbeenpublishedelsewhereinwholeorinpart.Allauthorshavereadandapprovedthecontent,andagreetosubmitforconsiderationforpublicationinthejournal.Therearenoanyethical/legalconflictsinvolvedinthearticle.ThismanuscripthasbeeneditedandproofreadbyMedjadenBioscienceLimited.Yourconsiderationforthismanuscriptishighlyappreciated.DisclaimerThetemplatesarepreparedbyMedjadenBioscienceLimited(,)asreferences,forourfellowChineseinvestigatorstopublishtheirresearcharticlesinEnglishjournals.Medjadenencouragesauthorstousethetemplatesinacreativewaybecausethesituationofeveryarticleisuniqueandisdifferentfromeachother.Copy/pasteofthistemplatewithoutconsiderationoftheuniquenatureofthearticlemayleadtotherejectionofthearticle.Medjadenisnotresponsible,inanyway,foranynegativedecisionmadebythejournals.Lookingforwardtohearingfromyousoon.Withkindregards,Yourssincerely,XXXX(nameofthecorrespondingauthor)XXX(titleofthecorrespondingauthor)CorrespondingauthorE-mail:
@#@DisclaimerThetemplatesarepreparedbyMedjadenBioscienceLimited(,)asreferences,forourfellowChineseinvestigatorstopublishtheirresearcharticlesinEnglishjournals.Medjadenencouragesauthorstousethetemplatesinacreativewaybecausethesituationofeveryarticleisuniqueandisdifferentfromeachother.Copy/pasteofthistemplatewithoutconsiderationoftheuniquenatureofthearticlemayleadtotherejectionofthearticle.Medjadenisnotresponsible,inanyway,foranynegativedecisionmadebythejournals.催稿信催稿信(Reminderletter)(Pleasedeletetheannotationsinitalicintheparentheses.)DearDr.orProf.XXXX(familynameoftheEditororEditor-in-Chiefwhoissuedthedecisionletter),Re:
@#@Ms#XXXX(numberofthemanuscriptifany)XXXX(titleofthearticle)Theabovementionedmanuscripthasbeensubmitted(orre-submitted)foroverX(3forsubmission,2forre-submission)months,butIhavenotheardofanydecisionfromthejournal.Iwillbemostgratefulifyoucouldletmeknowthecurrentstatusofthemanuscript.Pleasealsoadviseifyouneedanyadditionalinformationforthemanuscript.Thankverymuchforyourconsideration,andlookforwardtohearingfromyousoon.Withkindregards,Yourssincerely,XXXX(nameofthecorrespondingauthor)XXX(titleofthecorrespondingauthor)CorrespondingauthorDisclaimerThetemplatesarepreparedbyMedjadenBioscienceLimited(,)asreferences,forourfellowChineseinvestigatorstopublishtheirresearcharticlesinEnglishjournals.Medjadenencouragesauthorstousethetemplatesinacreativewaybecausethesituationofeveryarticleisuniqueandisdifferentfromeachother.Copy/pasteofthistemplatewithoutconsiderationoftheuniquenatureofthearticlemayleadtotherejectionofthearticle.Medjadenisnotresponsible,inanyway,foranynegativedecisionmadebythejournals.回复信回复信(Reply/ResponseLetter)美捷登主编在丁香园谈如何回复编辑和审稿人(暨友情修改回复信)http:
@#@/(Pleasedeletetheannotationsinitalicintheparentheses.)DearDr.orProf.XXXX(familynameoftheEditororEditor-in-Chiefwhoissuedthedecisionletter),Thankyouverymuchforyourletterandadvice.Wehaverevisedthemanuscript,andwouldliketore-submititforyourconsideration.Wehaveaddressedthecommentsraisedbythereviewers,andtheamendmentsarehighlightedinredintherevisedmanuscript.Pointbypointresponsestothereviewerscommentsarelistedbelowthisletter.ThismanuscripthasbeeneditedandproofreadbyMedjadenBioscienceLimited.Wehopethattherevisedversionofthemanuscriptisnowacceptableforpublicationinyourjournal.Ilookforwardtohearingfromyousoon.Withbestwishes,Yourssincerely,XXXX(nameofthecorrespondingauthor)DisclaimerThetemplatesarepreparedbyMedjadenBioscienceLimited(,)asreferences,forourfellowChineseinvestigatorstopublishtheirresearcharticlesinEnglishjournals.Medjadenencouragesauthorstousethetemplatesinacreativewaybecausethesituationofeveryarticleisuniqueandisdifferentfromeachother.Copy/pasteofthistemplatewithoutconsiderationoftheuniquenatureofthearticlemayleadtotherejectionofthearticle.Medjadenisnotresponsible,inanyway,foranynegativedecisionmadebythejournals.XXX(titleofthecorrespondingauthor)CorrespondingauthorDisclaimerThetemplatesarepreparedbyMedjadenBioscienceLimited(,)asreferences,forourfellowChineseinvestigatorstopublishtheirresearcharticlesinEnglishjournals.Medjadenencouragesauthorstousethetemplatesinacreativewaybecausethesituationofeveryarticleisuniqueandisdifferentfromeachother.Copy/pasteofthistemplatewithoutconsiderationoftheuniquenatureofthearticlemayleadtotherejectionofthearticle.Medjadenisnotresponsible,inanyway,foranynegativedecisionmadebythejournals.Wewouldliketoexpressoursincerethankstothereviewersfortheconstructiveandpositivecomments.RepliestoReviewer1SpecificComments1.JNK2mRNAlevelsarerelativelyhigherinSW1116cells,COLO205andAGScells,whencomparedtotheothercelllinestested.However,SimilarlyJNKproteinslevelsarehighinthethreecelllines.However,islowinSW1116cells,comparedtotheothertwo.Inaddition,theSPcompoundinducedhigherlevelsofapoptosisinAGSandCOLO205cells.ItseemsthatinhibitionofphosphorylatedJNKmaybethemechanismbywhichtheSPcompoundisactinginthesecells.TheauthorsshoulddiscussthispotentialpossibilityintheDiscussionsection.Answer:
@#@SeveralsentenceshavebeenchangedintheDiscussion(page12,paragraph1)intherevisedversiontoaddressthisissue.2.Theauthorshouldmentionwhytheychosethesixcelllinesfortheirstudy.Answer:
@#@AGS,HT-29andCOLO205arewidelyusedgastrointestinalcelllinesforMAPKpathwaystudy.AndtherestthreecelllinesarecommonlyinvestigatedinourLab.3.Surprisingly,inhibitionofMKN-45cellproliferationdidnotoccuruntil72h.Couldthisbeduetoslowergrowthofthecellsinthefirstplace?
@#@Answer:
@#@Actually,wedidntfindMKN-45cellgrowobviouslyslowerthantheothercelllinesinourstudy.DisclaimerThetemplatesarepreparedbyMedjadenBioscienceLimited(,)asreferences,forourfellowChineseinvestigatorstopublishtheirresearcharticlesinEnglishjournals.Medjadenencouragesauthorstousethetemplatesinacreativewaybecausethesituationofeveryarticleisuniqueandisdifferentfromeachother.Copy/pasteofthistemplatewithoutconsiderationoftheuniquenatureofthearticlemayleadtotherejectionofthearticle.Medjadenisnotresponsible,inanyway,foranynegativedecisionmadebythejournals.4.Inthestudieswiththecaspaseinhibitor,theauthorshaveonlymentionedtheirresultsinCOLO205.ItwouldbeexpectedthatasimilarresultwouldhavebeenobtainedforAGScellsaswell.Ifso,forthesakeofcompletenessofthereporttheycouldaddalinestatingso.Answer:
@#@ThestatementofAGShasbeenaddedinRes";}